VIVIMEDLAB · Materials · 2026-08-21

Vivimed Labs Ltd

Stage 4 · wk 15In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹6.2
+4.87% today
₹52 Cr · Micro cap
About this companyMaterials· Specialty Chemicals
Expand ▾

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.

Visit company website →
vs 52W High
-76.5%
₹4.9 lo₹26.6 hi
76.5% below 52W high — deep Stage 4 damage
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 15
1w13w26w
Week 15 — established downtrend
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
-13.1%
200 DMA: ₹7.2 · rising
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
0.85x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
↗ ⇈
Accelerating · MA20 +1.3% vs MA50 -8.1% / 10d
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Materials
↑ Building
Stage 2%
39.3%
20d Δ
+8.0pp
1M return
+2.7%
3M return
+1.4%
Sector Stage-2 % · last 20 days
Sector has 158 Stage 2 leaders. See Materials Stage 2 →
Industry
Specialty Chemicals
↑ Building
Stage 2%
60.3%
20d Δ
+17.6pp
1M return
+5.5%
3M return
+20.1%
Industry Stage-2 % · last 20 days
Industry has 40 Stage 2 leaders. See Specialty Chemicals Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-26 → 2026-08-21
S4 134w
S4 15w
2023-05-262026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 134w → S2 11w → S3 9w → S4 15w current
Total tracked: 169 weeks across 4 stage runs.
1M
+20.7%
3M
-4.6%
6M
-11.4%
YTD
-68.1%
1Y
+26.1%
Scan Membership
Breakout Watch
Latest: 2025-12-18
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S4
Wk 15 · Vol —x
2026-08-20S4
Wk 15 · Vol —x
2026-08-19S4
Wk 15 · Vol —x
2026-08-18S4
Wk 15 · Vol —x
2026-08-17S4
Wk 15 · Vol —x
2026-08-14S4
Wk 14 · Vol —x
2026-08-13S4
Wk 14 · Vol —x
2026-08-12S4
Wk 14 · Vol —x
2026-08-11S4
Wk 14 · Vol —x
2026-08-10S4
Wk 14 · Vol —x
2026-08-07S4
Wk 13 · Vol —x
2026-08-06S4
Wk 13 · Vol —x
Sector Peers — Stage 2All →
COMSYN
wk 10 · -1.2% from hi
9.6
GULFPETRO
wk 9 · -0.5% from hi
9.6
MMP
wk 11 · -1.1% from hi
9.4
SIGIND
wk 2 · -1.4% from hi
9.2
SBCL
wk 15 · -10.1% from hi
9.0
Moving averages & range
50 DMA
₹5.5
200 DMA
₹7.2
52W High
₹26.6
52W Low
₹4.9
5D Low
₹5.2
Resistance levels (recent highs)
20d High
₹6.2
60d High
₹6.7
120d High
₹7.8
250d High
₹26.6
Next resistance
+7.7%
to 60d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.